Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Skin Diseases × Cetuximab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 256 Squamous Cell Carcinoma of Head and Neck 132 Head and Neck Neoplasms 115 Carcinoma, Non-Small-Cell Lung 82 Colonic Neoplasms 73 Rectal Neoplasms 67 Neoplasm Metastasis 59 Neoplasms 47 Pancreatic Neoplasms 35 Carcinoma, Squamous Cell 31 Lung Neoplasms 29 Esophageal Neoplasms 23 Stomach Neoplasms 19 Recurrence 19 Breast Neoplasms 19 Laryngeal Neoplasms 16 Mouth Neoplasms 15 Carcinoma 15 Esophageal Squamous Cell Carcinoma 13 Adenocarcinoma Of Esophagus 12 Tongue Neoplasms 11 Oropharyngeal Neoplasms 11 Hypopharyngeal Neoplasms 10 Salivary Gland Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Ovarian Neoplasms 9 Adenocarcinoma of Lung 9 Uterine Cervical Neoplasms 8 Colorectal Cancer Metastatic 8 Nasopharyngeal Carcinoma 7

Interventions

binimetinib 2 Aminolevulinic Acid 2 palbociclib 1 methyl 5-aminolevulinate 1 ipatasertib 1 exemestane 1 encorafenib 1 baricitinib 1 atezolizumab 1 Vemurafenib 1 VP-102 1 Spironolactone 1 Sodium Chloride 1 Radiotherapy 1 Radiation 1 Photochemotherapy 1 Paclitaxel 1 Low-Level Light Therapy 1 Leuprolide 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Equipment and Supplies 1 Docetaxel 1 Dacarbazine 1 Cetuximab 1 Capecitabine 1 Cantharidin 1 Botulinum Toxins, Type A 1 BF-200 ALA 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00240682 2012-02-22

CTXSCC

Centre Hospitalier of Chartres

Phase 2 Completed

Carcinoma, Squamous Cell, Skin Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡